ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma
ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma
Active, not recruiting · NCT05479708 · Registry updated 2026-04-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma | Neoplasm, Residual, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Active, not recruiting | Not stated | 2026-04-08 | NCT05479708 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BAIYONG SHEN | 1 |
| GeneCast Biotechnology Co., Ltd. | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine | Shanghai | China | 27 |